Crinetics Pharmaceuticals (CRNX) Receivables - Net (2025 - 2026)
Crinetics Pharmaceuticals (CRNX) recorded quarterly Receivables - Net of $5.7 million in Q1 2026, up 859.97% quarter-over-quarter from $592000.0 in Q4 2025.
Crinetics Pharmaceuticals (CRNX) Receivables - Net (2025 - 2026) Analysis & Trends
Crinetics Pharmaceuticals' Receivables - Net history runs 2 years deep, the most recent figure standing at $5.7 million for Q1 2026.
- In Q1 2026, Receivables - Net changed N/A year-over-year to $5.7 million; the TTM figure through Mar 2026 stood at $5.7 million (changed N/A YoY), while the FY2025 annual figure was $592000.0, changed N/A from the prior year.
- Receivables - Net was $5.7 million for Q1 2026 at Crinetics Pharmaceuticals, up from $592000.0 in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $5.7 million in Q1 2026 to a low of $592000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Crinetics Pharmaceuticals | 3.75 Bn | 3.75 Bn | 10.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.68 Mn |
| Mar 31, 2026 | 5.68 Mn |
| Dec 31, 2025 | 592,000.00 |
| Dec 31, 2025 | 592,000.00 |